Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × cemiplimab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Skin Neoplasms 3 Carcinoma, Renal Cell 3 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sinonasal Squamous Cell Carcinoma 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mycosis Fungoides 1 Mouth Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Laryngeal Neoplasms 1 Hemangiosarcoma 1 HPV-Related Squamous Cell Carcinoma 1 Gliosarcoma 1 Eyelid Squamous Cell Carcinoma 1 Carcinoma, Basal Cell 1

Interventions

Carboplatin 7 Cisplatin 6 pembrolizumab 5 Radiotherapy 5 Paclitaxel 4 Cetuximab 4 Drug Therapy 3 toripalimab 2 osimertinib 2 X-Rays 2 Fulvestrant 2 Fluorouracil 2 Chemoradiotherapy 2 trastuzumab deruxtecan 1 tisotumab vedotin 1 tislelizumab 1 ribociclib 1 pralsetinib 1 pamiparib 1 palbociclib 1 monalizumab 1 fludarabine 1 exemestane 1 entrectinib 1 disitamab vedotin 1 Therapeutics 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡